Table 1.
Prognostic factor | Number (%) |
---|---|
Sex, male (%) | 74 (63) |
Age (year) | 74.4 ± 12.7 |
Patient delay in hospital visit (year) | 2.97 ± 4.1 |
Tumour size (mm) | 28.3 ± 28.7 |
Lymph node metastasis | 12 (10.3) |
TNM stage (1) | |
Stage I | 56 (47.9) |
Stage II | 38 (32.5) |
Stage III | 17 (14.5) |
Stage IV | 6 (5.1) |
Radiation related | 3 (2.6) |
Rapid growth | 7 (6.0) |
Perineural invasion | 3 (2.6) |
Lymphovascular invasion | 3 (2.6) |
Degree of differentiation | |
Well | 67 (57.3) |
Moderate | 27 (23.1) |
Poor | 7 (6.0) |
Tumour site | |
Temporal head | 8 (6.8) |
Frontal head | 4 (3.4) |
Eye lid | 1 (0.9) |
Cheek | 24 (20.5) |
Ear | 10 (8.5) |
Nose | 4 (3.4) |
Lip | 5 (4.3) |
Upper extremities | 5 (4.3) |
Finger | 8 (6.8) |
Hand | 8 (6.8) |
Trunk | 6 (5.1) |
Lower extremities | 19 (16.2) |
Planter of the foot | 3 (2.6) |
Dorsum of the foot | 3 (2.6) |
Heel | 2 (1.7) |
Digit of the foot | 7 (6.0) |
Preceding lesion | |
Actinic keratosis | 29 (24.8) |
Basal cell carcinoma | 1 (0.9) |
Bowen disease | 17 (14.5) |
Burn | 3 (2.6) |
Epidermal cyst | 1 (0.9) |
Keratoacanthoma | 6 (5.1) |
Pustulosis palmaris and plantaris | 1 (0.9) |
Radiation keratosis | 1 (0.9) |
Scar | 4 (3.4) |
Other squamous cell carcinoma | 1 (0.9) |
Trichilemmal cyst | 1 (0.9) |
Ulcer | 10 (8.5) |
Unknown | 42 (35.9) |
Note: (1)Stage was described using UICC (7th edition, 2009) [1].